PATH Malaria Vaccine Initiative

Positive study results for world's most clinically advanced malaria vaccine candidate

Data in New England Journal of Medicine bolster case for RTS,S

Partnering with us

We are pursuing a range of vaccine development approaches with an expanding circle of industry, academic, and government partners.

Our portfolio

We support a diversity of malaria vaccine candidates at different stages of development.

View the vaccine portfolio»

What we do and how we do it

MVI provides funding and technical support to partners worldwide to accelerate the development of malaria vaccines. MVI also works to ensure that malaria vaccines will reach those who need them.
Find out more»

Photo: Sanaria Inc.

News and announcements

MVI appoints new Director of Clinical Research and Development

MVI is pleased to welcome Dr. Santiago Ferro to its Leadership Team as Director of Clinical Development. In this role he will oversee the development of malaria vaccine candidates in MVI's portfolio as they move into human trials.

Read more (21 KB PDF)»

MVI announces collaboration with US Food and Drug Administration

MVI announces a collaboration with the US Food and Drug Administration (FDA) to develop laboratory tests to predict the level of safety and activity of vaccine candidates based on live, attenuated (weakened) malaria parasites